Sexual dysfunction: The unspoken side effect of antipsychotics

European Psychiatry

Volumn 13, Issue SUPPL.1, 1998, Pages

  Peuskens, J ^a   Sienaert, P ^a   De Hert, M ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Antipsychotics; Schizophrenia; Sexual dysfunction

Indexed keywords

CLOZAPINE; FLUPHENAZINE; HALOPERIDOL; NEUROLEPTIC AGENT; QUETIAPINE; RISPERIDONE; THIORIDAZINE;

CONFERENCE PAPER; DRUG EFFECT; FEMALE SEXUAL DYSFUNCTION; HUMAN; MALE SEXUAL DYSFUNCTION; PRIORITY JOURNAL; PSYCHIATRIST; SCHIZOPHRENIA; SEXUAL DYSFUNCTION;

EID: 0031904920     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-9338(97)89490-4     Document Type: Article

References (33)

1. Aizenberg D, Zemishlany Z, Dorfman-Entrol P, Weiznan A. Sexual dysfunction in male schizophrenic patients. J Clin Psychiatry 1995;56:137-41
2. Akhtar S, Thomson JA. Schizophrenia and sexuality: a review and a report of twelve unusual cases - Part II. J Clin Psychiatry 1980;41: 166-74
3. Arato M, Erdos A, Polgar M. Endocrinological changes in patients with sexual dysfunction under long-term antipsych otic treatment. Pharmakopsychiatrie Neuropsychopharmakol 1979;12:426-31
4. Barnes TRE, Harvey CA. Psychiatric drugs and sexuality. In: Riley AJ, Peet M, Wilson C, eds. Sexual Pharmacology. Oxford: Oxford Medical Publications, 1993;176-96
5. Berger SH. Trifluoperazine and haloperidol: sources of ejaculatory pain? Am J Psychiatry 1979;136:650
6. Cournos F, Guido JR, Coomaraswamy S, Meyer-Bahlburg H, Sugden R, Horwath E. Sexual activity and risk of HIV infection among patients with schizophrenia Am J Psychiatry 1994;151: 228-32
7. Fañanás L, Bertranpetit J. Reproductive rates in families of schizophrenic patients in a case-control study. Acta Psychiatr Scand 1995; 91:202-4
8. Finn SE, Bailey JM, Schultz RT, Faber R. Subjective utility ratings of neuroleptics in treating schizophrenia. Psychol Med 1990;35: 843-8
9. Fleischhacker WW, Meise U, Günther V, Kurz M. Compliance with antipsychotic drug treatment: influence of side effects. Acta Psychiatr Scand 1994;89:11-15
10. Ghadirian AM, Chouinard G, Annable L. Sexual dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic outpatients. J Nerv Ment Dis 1982;170:463-7
11. Gitlin MJ. Psychotropic medications and their effects on sexual function: diagnosis, biology, and treatment approaches. J Clin Psychiatry 1994;55:406-13
12. Hamner M, Arvanitis L, Miller B, Link C, Hong W. Plasma prolactin in schizophrenia subjects treated with Seroquel. Psycopharmacol Bull 1996;32:107-110
13. Kaplan HS. The new sex therapy. Hamondsworth: Penguin, 1974
14. Kelly JA, Murphy DA, Bahr GR, Brasfield TL, Davis DR, Hauth AC et al. AIDS/HIV risk behaviour among the chronic mentally ill. Am J Psychiatry 1992;149:886-9
15. Kotin J, Wibert DE, Verburg D, Soldinger SM. Thioridazine and sexual dysfunction. Am J Psychiatry 1976;133:82-5
16. Lane A, Byrne M, Mulvaney F, Kinsella A, Waddington JL, Walsh D et al. Reproductive behaviour in schizophrenia relative to other mental disorders: evidence for increased fertility in men despite decreased marital rate. Acta Psychiatr Scand 1995;91:222-8
17. Lingjaerde O, Ahlfors VG, Dencker SJ, Eigen K. The UKU side effect rating scale for psychotropic drugs and a cross sectional study of side effects in antipsychotic patients. Acta Psychiatr Scand Suppl 1987;334:76
18. McKinnon K, Cournos F, Meyer Bahlburg HFL, Guido JR, Caraballo LR, Margoshes ES et al. Reliability of sexual risk behaviour interviews with psychiatric patients. Am J Psychiatry 1993;150: 972-4
19. Meston CM, Gorzalka BB. Psychoactive drugs and human sexual behaviour: the role of serotonergic activity. J Psychoactive Drugs 1992;24:1-40
20. Mitchell JE, Popkin MK. Antipsychotic drug therapy and sexual dysfunction in men. Am J Psychiatry 1982;139:633-7
21. Nestoros JN, Lehmann HE, Ban TA. Sexual behaviour of the male schizophrenic: the impact of illness and medications. Arch Sex Behav 1981;10:421
22. Peacock L, Solgard T, Lublin H, Gerlach J. Clozapine verses typical antipsychotics: effects and side effects. Neuropsychopharm 1994;10:228-354
23. Peuskens J. Risperidone in the treatment of patients with chronic schizophrenia: a multinational, multicentre, double-blind, parallel group study versus haloperidol. Brit J Psychiatry 1995;166: 712-26
24. Pfeiffer W, Kockott G, Fischl B, Schleuning G. Unerwünschte Wirkungen psychopharmakologischer Langzeittherapie auf die sexuellen Funktionen. Psychiatr Prax 1991;18:92-8
25. Pollack MH, Reiter S, Hammerness P. Genitourinary and sexual adverse effects of psychotropic medication, Int J Psychiatry in Mediane 1992;22:305-27
26. Riley AJ. Alpha adrenoceptors and human sexual function. In: Bancroft J, ed. The Pharmacology of Sexual Function and Dysfunction. Amsterdam: Elsevier Science BV 1995;307-22
27. Schiavi RC, Segraves RT. The biology of sexual function. Psychiatr Clin North Am 1995;18:7-23
28. Segraves RT. Effects of psychotropic drugs on human erection and ejaculation. Arch Gen Psychiatry 1989;46:275-84
29. Strauss B, Gross J. Psychopharmakabedingte Veränderungen der Sexualität (Häufigkeit und Stellenwert in der psychiatrischen Praxis. Psychiatr Prax 1984;11:49-55
30. Sullivan G, Lukoff D. Sexual side effects of antipsychotic medication: evaluation and interventions. Hosp Community Psychiatry 1990;41:1238-41
31. Susser E, Valacnia E, Miller M, Tsai WY, Meyer-Bahlburg H, Conover S. Sexual behaviour of homeless mentally ill men at risk for HIV. Am J Psychiatry 1995;152:583-7
32. Verhulst J, Schneidman B. Schizophrenia and Sexual Functioning. Hosp Community Psychiatry 1981;32:259-62
33. Wilson CA. Pharmacological targets for the control of male and female sexual behaviour. In: Riley AJ, Peet M. Wilson C, eds. Sexual Pharmacology. Oxford: Oxford Medical Publications, 1993:1-58